-
Bulgarian Hospitals are accumulating debts from drugs
12.04.2012Hospitals borrow from drugs and severe cases, emergency patients without health insurance, showed "Press"
прочети -
The Best Drug Companies Of The Past 15 Years
12.04.2012Drug company’s main job is to invent new medicines and get them to patients.
прочети -
Twelve Ways Leaders Fail New Managers
14.09.2011When you place a colleague or a new hire into a management position, you'd better not abandon the poor soul
прочети -
Amazing therapy wipes out leukemia in study
14.09.2011NEW YORK (AP) — Scientists are reporting the first clear success with a new approach for treating leukemia — turning the patients' own blood cells into assassins that hunt and destroy their cancer cells.
прочети -
Allergan Patents Valid, Infringed by Teva, Judge Decides
14.09.2011Allergan Inc.’s patents for the glaucoma treatment Lumigan are valid and are infringed by Israel’s Teva Pharmaceutical Industries Ltd. (TEVA), a federal judge ruled today.
прочети -
Gail Porter 'still angry' about being sectioned
14.09.2011Former TV presenter Gail Porter says she is still angry at the lack of treatment she received when she was sectioned against her will.
прочети -
Amgen backs $30M venture round for IBS-focused Ardelyx
02.09.2011Amgen's venture arm has chipped in to a $30 million B round for Fremont, CA-based Ardelyx. The biotech plans to use a good deal of the cash to complete a Phase II study of a lead drug for constipation-predominant irritable bowel syndrome.
прочети -
Former Pfizer employees start new firm at Sandwich site
02.09.2011A company set up by a group of former Pfizer employees is one of the the first businesses to be based at the east Kent site which Pfizer is leaving.
прочети -
Reframe Your Strategy to Avoid Hidden Biases
02.09.2011The last decade has seen an increased appreciation of behavioral economics and its effect on the practice of management.
прочети -
Jennerex cheered by early efficacy data for cancer-killing virus
02.09.2011A small, mid-stage study of Jennerex's genetically engineered virus offered some important preliminary proof-of-concept data on its ability to zero in on cancer cells with just a single infusion.
прочети
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961
